No payment accepted from any clinic or pharmacy listed. No referral fees, no coupon codes, no partnerships.How we make money
← GLP Success
Comparison

Goby Meds vs Ivim Health

Independent, side-by-side. Same methodology, same sourcing standard, no payment accepted from either. Prices are observed market pricing (snapshot 2026-07-20); receipts are computed from sourced records.

Goby MedsIvim Health
VerdictProfile in progressProfile in progress
Tirzepatide pricefrom $166/mo (3-mo prepay)from $548/mo (monthly plan)
Semaglutide pricefrom $133/mo (3-mo prepay)from $299/mo (monthly plan)
Pharmacy receiptNames its pharmacy (The Pharmacy Hub, Sevens Cells +2) — The Pharmacy Hub, Sevens Cells +2 state-verified by us in up to 15 states. Pick your state to check yours.Fills through Empower, Tailor Made per market data — Empower is an FDA-registered 503B outsourcing facility (federal cGMP oversight). Pick your state to check the rest.
Care receiptCare is outsourced to Beluga Health, CareValidate and OpenLoop — contract medical groups named on the clinic's own site. The brand doesn't employ your clinician.In-house clinicians; check-ins and coaching on record.
Review integrityClean review record — 10% unprompted on 616 reviews, within our 40% threshold.Review-integrity flag — 66% of its Trustpilot reviews are unprompted "organic" posts, past our 40% gaming threshold.
Company addressIts listed address is a registered-agent or mailbox service — no operating location stands behind the brand's listed address.Lists a real-looking operating address on its own site.
PharmacyIn reviewIn review
Clinical supportIn reviewIn review
Patient supportIn reviewIn review
ValueIn reviewIn review
Ships to50 statesIn review
Pharmacy modelCash-pay telehealth that routes prescriptions to 503A and/or 503B compounding pharmacy partners; GobyMeds' own safety page names four dispensing pharmacies, and third-party reviewers report the pharmacy name is shown on the medication-selection screen during intake.Telehealth platform that does not compound medication itself; a licensed provider evaluates the patient and prescribes compounded semaglutide or tirzepatide, which is then filled by external state-licensed compounding pharmacies. Ivim describes these as FDA-regulated, state-licensed compounding pharmacies and references Certificate of Analysis, sterility, potency, pH, and endotoxicity testing, but does not publicly name them. The FDA warning letter (02/20/2026) found that Ivim is not the compounder of the products despite product labels bearing the Ivim name.
Red flags on file31

Full profiles: Goby Meds · Ivim Health
State-aware license reads: the tirzepatide price board →